Cargando…

The potential convergence of NLRP3 inflammasome, potassium, and dopamine mechanisms in Parkinson’s disease

The pathology of Parkinson’s disease (PD) is characterized by α-synuclein aggregation, microglia-mediated neuroinflammation, and dopaminergic neurodegeneration in the substantia nigra with collateral striatal dopamine signaling deficiency. Microglial NLRP3 inflammasome activation has been linked ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pike, Adrianne F., Szabò, Ildikò, Veerhuis, Robert, Bubacco, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948240/ https://www.ncbi.nlm.nih.gov/pubmed/35332154 http://dx.doi.org/10.1038/s41531-022-00293-z

Ejemplares similares

Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
por: Pike, Adrianne F., et al.
Publicado: (2022)

α‐Synuclein evokes NLRP3 inflammasome‐mediated IL‐1β secretion from primary human microglia
por: Pike, Adrianne F., et al.
Publicado: (2021)

Impaired dopamine metabolism in Parkinson’s disease pathogenesis
por: Masato, Anna, et al.
Publicado: (2019)

Distinct Molecular Mechanisms Underlying Potassium Efflux for NLRP3 Inflammasome Activation
por: Xu, Ziwei, et al.
Publicado: (2020)

Itaconate Attenuates Neuroinflammation and Exerts Dopamine Neuroprotection in Parkinson’s Disease through Inhibiting NLRP3 Inflammasome
por: Sun, Guoqing, et al.
Publicado: (2022)

Fyn amplifies NLRP3 inflammasome signaling in Parkinson's disease
por: Panicker, Nikhil, et al.
Publicado: (2019)

Role of NLRP3 Inflammasome in Parkinson’s Disease and Therapeutic Considerations
por: Nguyen, Linh Thi Nhat, et al.
Publicado: (2022)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
por: Zhang, Tan, et al.
Publicado: (2021)

The two pore potassium channel THIK‐1 regulates NLRP3 inflammasome activation
por: Drinkall, Samuel, et al.
Publicado: (2022)

The Convergence of Dopamine and α-Synuclein: Implications for Parkinson’s Disease
por: Mor, Danielle E, et al.
Publicado: (2018)

Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases
por: Guan, Yadi, et al.
Publicado: (2020)

Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes
por: Ding, Sujuan, et al.
Publicado: (2019)

Interaction between autophagy and the NLRP3 inflammasome in Alzheimer’s and Parkinson’s disease
por: Lu, Ranran, et al.
Publicado: (2022)

Ellagic Acid Protects Dopamine Neurons via Inhibition of NLRP3 Inflammasome Activation in Microglia
por: He, Xue-mei, et al.
Publicado: (2020)

Dopamine activates NF-κB and primes the NLRP3 inflammasome in primary human macrophages
por: Nolan, R.A., et al.
Publicado: (2019)

Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
por: Soraci, Luca, et al.
Publicado: (2022)

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
por: Kelley, Nathan, et al.
Publicado: (2019)

A novel mechanism for NLRP3 inflammasome activation
por: Zhang, Tan, et al.
Publicado: (2022)

An update on the regulatory mechanisms of NLRP3 inflammasome activation
por: Paik, Seungwha, et al.
Publicado: (2021)

The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis
por: Artlett, Carol M.
Publicado: (2022)

Caspase-11 Interaction with NLRP3 Potentiates the Noncanonical Activation of the NLRP3 Inflammasome
por: Moretti, Julien, et al.
Publicado: (2022)

NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
por: Han, Qiu-Qin, et al.
Publicado: (2023)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

RNA viruses promote activation of the NLRP3 inflammasome through cytopathogenic effect-induced potassium efflux
por: da Costa, Leandro Silva, et al.
Publicado: (2019)

The Critical Role of Potassium Efflux and Nek7 in Pasteurella multocida-Induced NLRP3 Inflammasome Activation
por: Wang, Yu, et al.
Publicado: (2022)

Editorial: NLRP3 Inflammasome: Regulatory Mechanisms, Role in Health and Disease and Therapeutic Potential
por: Chernikov, Oleg V., et al.
Publicado: (2021)

The NLRP3 inflammasome is a potential mechanism and therapeutic target for perioperative neurocognitive disorders
por: Li, Jiayue, et al.
Publicado: (2023)

BAG3 promotes autophagy and suppresses NLRP3 inflammasome activation in Parkinson’s disease
por: Ying, Zhong-Ming, et al.
Publicado: (2022)

NLRP3 inflammasome activation mechanism and its role in autoimmune liver disease: Role of NLRP3 inflammasome in autoimmune liver disease
por: Guan, Yanling, et al.
Publicado: (2022)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

Recent insights into the molecular mechanisms of the NLRP3 inflammasome activation
por: Próchnicki, Tomasz, et al.
Publicado: (2016)

Contradictory Effects of NLRP3 Inflammasome Regulatory Mechanisms in Colitis
por: Wagatsuma, Kohei, et al.
Publicado: (2020)

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors
por: Zhan, Xiaoyan, et al.
Publicado: (2023)

NLRP3 inflammasome in digestive diseases: From mechanism to therapy
por: Qiang, Rui, et al.
Publicado: (2022)

The NLRP3 Inflammasome: Role and Therapeutic Potential in Pain Treatment
por: Starobova, Hana, et al.
Publicado: (2020)

The Role of NLRP3 Inflammasome in Pericarditis: Potential for Therapeutic Approaches
por: Mauro, Adolfo G., et al.
Publicado: (2021)

Chalcone: A potential scaffold for NLRP3 inflammasome inhibitors
por: Thapa, Pritam, et al.
Publicado: (2023)

Heat‐killed Lactobacillus murinus confers neuroprotection against dopamine neuronal loss by targeting NLRP3 inflammasome
por: Fan, Hong‐Xia, et al.
Publicado: (2022)

Sensing low intracellular potassium by NLRP3 results in a stable open structure that promotes inflammasome activation
por: Tapia-Abellán, Ana, et al.
Publicado: (2021)

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
por: Saresella, Marina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0813fvshkrkk33hqb08abpdatp